260 related articles for article (PubMed ID: 34702204)
1. "Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors".
Gernier F; Ahmed-Lecheheb D; Pautier P; Floquet A; Nadeau C; Frank S; Alexandre J; Selle F; Berton-Rigaud D; Kalbacher E; Orfeuvre H; Lortholary A; Augereau P; Labombarda F; Perrier L; Grellard JM; Licaj I; Clarisse B; Savoye AM; Bourien H; De La Motte Rouge T; Kurtz JE; Kerdja K; Lelaidier A; Charreton A; Ray-Coquard I; Joly F
BMC Cancer; 2021 Oct; 21(1):1147. PubMed ID: 34702204
[TBL] [Abstract][Full Text] [Related]
2. Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study.
Joly F; Ahmed-Lecheheb D; Kalbacher E; Heutte N; Clarisse B; Grellard JM; Gernier F; Berton-Rigaud D; Tredan O; Fabbro M; Savoye AM; Kurtz JE; Alexandre J; Follana P; Delecroix V; Dohollou N; Roemer-Becuwe C; De Rauglaudre G; Lortholary A; Prulhiere K; Lesoin A; Zannetti A; N'Guyen S; Trager-Maury S; Chauvenet L; Abadie Lacourtoisie S; Gompel A; Lhommé C; Floquet A; Pautier P
Ann Oncol; 2019 May; 30(5):845-852. PubMed ID: 30851097
[TBL] [Abstract][Full Text] [Related]
3. Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salomé study including 469 patients. A TMRG and GINECO group study.
Hanvic B; Lecuru F; Vanacker H; Pautier P; Narducci F; Cherifi F; Floquet A; Angeles MA; Berton D; Pomel C; Kalbacher E; Provansal M; Fernandez Y; Rouge TM; Roméo C; Laas E; Morice P; Hudry D; Meriaux E; Guyon F; Illac-Vauquelin C; Selle F; Meeus P; Genestie C; Salleron J; Ray-Coquard I
Gynecol Oncol; 2023 Jul; 174():190-199. PubMed ID: 37210929
[TBL] [Abstract][Full Text] [Related]
4. Impact of a one-year supervised physical activity program on long-term cancer-related fatigue and mediating effects of the gut microbiota in metastatic testicular cancer patients: protocol of the prospective multicentre, randomized controlled phase-III STARTER trial.
Noh H; Anota A; Mongondry R; Meyrand R; Dupuis C; Schiffler C; Marijnen P; Rinaldi S; Lachuer J; Keski-Rahkonen P; Gunter MJ; Fléchon A; Fervers B; Pérol O
BMC Cancer; 2024 Jan; 24(1):84. PubMed ID: 38225551
[TBL] [Abstract][Full Text] [Related]
5. The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors.
Brown J; Shvartsman HS; Deavers MT; Ramondetta LM; Burke TW; Munsell MF; Gershenson DM
Gynecol Oncol; 2005 May; 97(2):489-96. PubMed ID: 15863149
[TBL] [Abstract][Full Text] [Related]
6. [Rare ovarian tumours: therapeutic strategies in 2010, national website observatory for rare ovarian cancers and delineation of referent centers in France].
Ray-Coquard I; Pautier P; Pujade-Lauraine E; Méeus P; Morice P; Treilleux I; Duvillard P; Alexandre J; Lhommé C; Selle F; Guastalla J
Bull Cancer; 2010 Jan; 97(1):123-35. PubMed ID: 20007069
[TBL] [Abstract][Full Text] [Related]
7. Fertility outcomes following surgery and multiagent chemotherapy in malignant ovarian germ cell tumor survivors: a survey study.
Bergamini A; Ramaswami R; Froeling F; Papanastasopoulos P; Short D; Aguiar X; Savage PM; Sarwar N; Kaur B; Saso S; Fotopoulou C; Sharma A; Rustin GJS; Seckl M
Int J Gynecol Cancer; 2023 Nov; 33(11):1750-1756. PubMed ID: 37931975
[TBL] [Abstract][Full Text] [Related]
8. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
[TBL] [Abstract][Full Text] [Related]
9. Therapy of advanced ovarian juvenile granulosa cell tumors.
Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy of ovarian germ cell tumors and sex cord stromal tumors.
Gershenson DM
Semin Surg Oncol; 1994; 10(4):290-8. PubMed ID: 8091071
[TBL] [Abstract][Full Text] [Related]
11. Late effects of treatment for germ cell tumors during childhood and adolescence.
Hale GA; Marina NM; Jones-Wallace D; Greenwald CA; Jenkins JJ; Rao BN; Luo X; Hudson MM
J Pediatr Hematol Oncol; 1999; 21(2):115-22. PubMed ID: 10206457
[TBL] [Abstract][Full Text] [Related]
12. The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study.
Lenck C; Chopin N; Gouy S; Bonsang-Kitzis H; Martinez-Gomez C; Radosevic-Robin N; Martin S; Lefeuvre-Plesse C; Lambaudie E; Leblanc E; Guyon F; Classe JM; Ramanah R; Beurrier F; Angeles MA; Pomel C; Joly F; de la Motte Rouge T; Provansal M; Lesoin A; Floquet A; Berton D; Kalbacher E; Chakiba C; Meeus P; Selle F; Treilleux I; Lecuru F; Pautier P; Ray-Coquard I
Gynecol Oncol; 2020 Apr; 157(1):78-84. PubMed ID: 32131977
[TBL] [Abstract][Full Text] [Related]
13. Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group study.
Matei D; Miller AM; Monahan P; Gershenson D; Zhao Q; Cella D; Champion VL; Williams SD
J Clin Oncol; 2009 Sep; 27(25):4142-9. PubMed ID: 19636015
[TBL] [Abstract][Full Text] [Related]
14. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary.
Tangir J; Zelterman D; Ma W; Schwartz PE
Obstet Gynecol; 2003 Feb; 101(2):251-7. PubMed ID: 12576247
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
[TBL] [Abstract][Full Text] [Related]
16. Management of rare ovarian cancers: the experience of the French website "Observatory for rare malignant tumours of the ovaries" by the GINECO group: interim analysis of the first 100 patients.
Ray-Coquard I; Weber B; Lotz JP; Tournigand C; Provencal J; Mayeur D; Treilleux I; Paraiso D; Duvillard P; Pujade-Lauraine E;
Gynecol Oncol; 2010 Oct; 119(1):53-9. PubMed ID: 20580063
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.
Bilici A; Inanc M; Ulas A; Akman T; Seker M; Babacan NA; Inal A; Bal O; Koral L; Sevinc A; Tufan G; Elkiran ET; Ustaalioglu BB; Yavuzsen T; Alkis N; Ozkan M; Gumus M
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6493-9. PubMed ID: 24377556
[TBL] [Abstract][Full Text] [Related]
18. Progressive resistance training and cancer testis (PROTRACT) - efficacy of resistance training on muscle function, morphology and inflammatory profile in testicular cancer patients undergoing chemotherapy: design of a randomized controlled trial.
Christensen JF; Andersen JL; Adamsen L; Lindegaard B; Mackey AL; Nielsen RH; Rørth M; Daugaard G
BMC Cancer; 2011 Aug; 11():326. PubMed ID: 21806789
[TBL] [Abstract][Full Text] [Related]
19. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
20. [Medical treatment in ovarian cancers newly diagnosed: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
de la Motte Rouge T; Ray-Coquard I; You B
Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):222-237. PubMed ID: 30709790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
